KUALA LUMPUR, Malaysia, June 24, 2025 /PRNewswire/ -- National Training Week (NTW) 2025 concluded with a groundbreaking 3.5 million participants, underscoring the region's growing commitment to upskilling, reskilling and inclusive lifelong learning.
As the second flagship platform under the ASEAN Year of Skills (AYOS) 2025, the NTW 2025 was spearheaded by Malaysia's Minister of Human Resources (KESUMA), The Honourable Steven Sim Chee Keong, through its agency, Human Resources Development Corporation (HRD Corp), as part of a unified regional agenda to future-proof ASEAN's workforce and expand access to learning and development (L&D).
At the launch of NTW 2025, Malaysian Prime Minister Dato' Seri Anwar Ibrahim underlined upskilling and reskilling as critical drivers of Malaysia's economic growth and regional competitiveness.
"A country (Malaysia) cannot afford to remain stagnant by relying on outdated training models and traditional approaches. It is time to equip our people, especially the younger generation, with new and future-relevant skills."
"Our teachers must be exposed to AI, just as our children must be educated in it. Only then can we begin to close the skills gap and ensure our people are prepared for what lies ahead," he added.
Minister Sim who also delivered a speech during the opening ceremony shared that, "In conjunction with NTW 2025, we have collaborated with the Ministry of Education Malaysia to launch an initiative to empower artificial intelligence (AI) among educators through the AI-4-Educators programme," adding that the training initiative through the Learning Management System (SiPP) platform is a collaboration between the Ministry of Education Malaysia and Human Resource Development Corporation (HRD Corp).
"This initiative, which records over 395,000 teachers from across the country participating from 7 April to 12 June 2025, has also been recognised by the Malaysia Book of Records for the largest participation of educators in an AI training programme," he said.
Held from 14 to 21 June, NTW 2025 introduced the theme "Learning Beyond Borders", opening almost 73,000 free training opportunities to ASEAN citizens through a mix of in-person, live online, hybrid coaching, and self-paced e-learning. More than 12.3 million learning hours were recorded, supported by over 1,500 course providers, delivering training value exceeding USD 46 million.
Among the most sought-after courses were:
- Generative AI for Everyone
- Cybersecurity Threat Management
- Drone Flying Skills for New Pilots
- Neurodiversity Virtual Training
- Using GenAI and ChatGPT
The NTW 2025 Learning Tours concluded in Perak, underscoring its position as Malaysia's National TVET Corridor and KESUMA-HRD Corp's commitment to industry-driven skills across ASEAN. At the Closing Ceremony, Perak Chief Minister Dato' Seri Saarani Mohamad reminded that while NTW has ended, its spirit and knowledge must carry on.
"We are now in a new era where manual tasks are being taken over by automation and AI systems, fundamentally changing how we work and the types of skills required by the market," he said.
NTW 2025 is one of seven flagship events under AYOS 2025, led by Malaysia to build a future-ready ASEAN workforce, alongside upcoming platforms such as the ASEAN Training Market Conference, ASEAN TVET Conference, National Human Capital Conference, Global Skills Forum, and the ASEAN Forum of Manpower Ministers. The portal remains open until December 2025, offering free, on-demand training regionwide.
Visit:
www.nationaltrainingweek.gov.my for NTW training opportunities
www.aseanyearofskills.org on AYOS 2025
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
NTW 2025 SETS RECORD WITH 3.5 MILLION PARTICIPANTS UNDER MALAYSIA'S LEADERSHIP OF AYOS 2025
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
